{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:41:08Z","timestamp":1765039268048},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s13277-015-3813-4","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T15:13:59Z","timestamp":1438182839000},"page":"455-462","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Transforming growth factor-\u03b2 signaling pathway cross-talking with ER\u03b1 signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro"],"prefix":"10.1007","volume":"37","author":[{"given":"Yang","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mulan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"issue":"8","key":"3813_CR1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10815-012-9784-0","volume":"29","author":"G Levy","year":"2012","unstructured":"Levy G, Hill MJ, Beall S, et al. Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances. J Assist Reprod Genet. 2012;29(8):703\u201312.","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"3813_CR2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000360083","volume":"77","author":"Y Shen","year":"2014","unstructured":"Shen Y, Ren ML, Xu J, Xu Q, Ding YQ, Wu ZC, et al. A multicenter case-control study on screening of single nucleotide polymorphisms in estrogen-metabolizing enzymes and susceptibility to uterine leiomyoma in Han Chinese. Gynecol Obstet Invest. 2014;77(4):224\u201330.","journal-title":"Gynecol Obstet Invest"},{"issue":"23","key":"3813_CR3","first-page":"3249","volume":"17","author":"Y Shen","year":"2013","unstructured":"Shen Y, Xu Q, Xu J, Ren ML, Cai YL. Environmental exposure and risk of uterine leiomyoma: an epidemiologic survey. Eur Rev Med Pharmacol Sci. 2013;17(23):3249\u201356.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"3813_CR4","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/e2536fcb-3ab3-44a0-8eab-91aaeb8e49b6","volume":"8","author":"Y Shen","year":"2013","unstructured":"Shen Y, Xu Q, Ren M, Feng X, Cai Y, Gao Y. Measurement of phenolic environmental estrogens in women with uterine leiomyoma. PLoS One. 2013;8(11), e79838.","journal-title":"PLoS One"},{"key":"3813_CR5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejogrb.2014.04.038","volume":"178","author":"Y Shen","year":"2014","unstructured":"Shen Y, Ren ML, Feng X, Gao YX, Xu Q, Cai YL. Does nonylphenol promote the growth of uterine fibroids? Eur J Obstet Gynecol Reprod Biol. 2014;178:134\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3813_CR6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejogrb.2014.03.052","volume":"178","author":"Y Shen","year":"2014","unstructured":"Shen Y, Ren ML, Feng X, Cai YL, Gao YX, Xu Q. An evidence in vitro for the influence of bisphenol A on uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol. 2014;178:80\u20133.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"3813_CR7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0030-1251476","volume":"28","author":"N Chegini","year":"2010","unstructured":"Chegini N. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med. 2010;28(3):180\u2013203.","journal-title":"Semin Reprod Med"},{"issue":"5","key":"3813_CR8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/molehr\/gam007","volume":"13","author":"Y Zhao","year":"2007","unstructured":"Zhao Y, Wen Y, Polan ML, Qiao J, Chen BH. Increased expression of latent TGF-beta binding protein-1 and fibrillin-1 in human uterine leiomyomata. Mol Hum Reprod. 2007;13(5):343\u20139.","journal-title":"Mol Hum Reprod"},{"key":"3813_CR9","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","volume":"16","author":"JM Norian","year":"2009","unstructured":"Norian JM, Malik M, Parker CY, Joseph D, Leppert PC, Segars JH, et al. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. Reprod Sci. 2009;16:1153\u201364.","journal-title":"Reprod Sci"},{"issue":"4","key":"3813_CR10","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2010-2131","volume":"96","author":"SK Halder","year":"2011","unstructured":"Halder SK, Goodwin JS, Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells. J Clin Endocrinol Metab. 2011;96(4):E754\u201362.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3813_CR11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0002-9440(10)62985-9","volume":"167","author":"KB Ewan","year":"2005","unstructured":"Ewan KB, Oketch-Rabah HA, Ravani SA, Shyamala G, Moses HL, Barcellos-Hoff MH. Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta1 in adult mice. Am J Pathol. 2005;167(2):409\u201317.","journal-title":"Am J Pathol"},{"issue":"3","key":"3813_CR12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10549-009-0590-z","volume":"121","author":"JD Figueroa","year":"2010","unstructured":"Figueroa JD, Flanders KC, Garcia-Closas M, Anderson WF, Yang XR, Matsuno RK, et al. Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics. Breast Cancer Res Treat. 2010;121(3):727\u201335.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"3813_CR13","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/humrep\/deh842","volume":"20","author":"J Wang","year":"2005","unstructured":"Wang J, Ohara N, Takekida S, et al. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells. Hum Reprod. 2005;20(6):1456\u201365.","journal-title":"Hum Reprod"},{"issue":"22","key":"3813_CR14","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1158\/1078-0432.CCR-12-3826","volume":"19","author":"MN Skor","year":"2013","unstructured":"Skor MN, Wonder EL, Kocherginsky M, Goyal A, Hall BA, Cai Y, et al. Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer. Clin Cancer Res. 2013;19(22):6163\u201372.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3813_CR15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074525","volume":"8","author":"K Stark","year":"2013","unstructured":"Stark K, Burger A, Wu J, Shelton P, Polin L, Li J. Reactivation of estrogen receptor a by vorinostat sensitizes mesenchymal-like triple-negative breast cancer to aminoflavone, a ligand of the aryl hydrocarbon receptor. PLoS One. 2013;8(9), e74525.","journal-title":"PLoS One"},{"issue":"3","key":"3813_CR16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1210\/jc.2012-3237","volume":"98","author":"MS Islam","year":"2013","unstructured":"Islam MS, Protic O, Giannubilo SR, Toti P, Tranquilli AL, Petraglia F, et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab. 2013;98(3):921\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3813_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","volume":"10","author":"T Maruo","year":"2004","unstructured":"Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update. 2004;10(3):207\u201320.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"3813_CR18","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","volume":"151","author":"H Ishikawa","year":"2010","unstructured":"Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE, Kurita T. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 2010;151(6):2433\u201342.","journal-title":"Endocrinology"},{"key":"3813_CR19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jchromb.2013.08.032","volume":"938","author":"F Zhou","year":"2013","unstructured":"Zhou F, Zhang L, Liu A, Shen Y, Yuan J, Yu X, et al. Measurement of phenolic environmental estrogens in human urine samples by HPLC-MS\/MS and primary discussion the possible linkage with uterine leiomyoma. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;938:80\u20135.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"3813_CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3858\/emm.2012.44.4.024","volume":"44","author":"X Di","year":"2012","unstructured":"Di X, Andrews DM, Tucker CJ, Yu L, Moore AB, Zheng X, et al. A high concentration of genistein down-regulates activin A, Smad3 and other TGF-\u03b2 pathway genes in human uterine leiomyoma cells. Exp Mol Med. 2012;44(4):281\u201392.","journal-title":"Exp Mol Med"},{"issue":"2","key":"3813_CR21","first-page":"913","volume":"86","author":"BS Lee","year":"2001","unstructured":"Lee BS, Nowak RA. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta. J Clin Endocrinol Metab. 2001;86(2):913\u201320.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3813_CR22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","volume":"73","author":"A Arici","year":"2000","unstructured":"Arici A, Sozen I. Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril. 2000;73(5):1006\u201311.","journal-title":"Fertil Steril"},{"key":"3813_CR23","doi-asserted-by":"crossref","unstructured":"Borahay MA, Al-Hendy A, Kilic GS, Boehning D. Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy. Mol Med. 2015 Apr 13. [Epub ahead of print].","DOI":"10.2119\/molmed.2014.00053"},{"issue":"8","key":"3813_CR24","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00018-013-1376-3","volume":"71","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Qiao JX, Shetty A, Wu G, Huang Y, Davidson NE, et al. Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. Cell Mol Life Sci. 2014;71(8):1549.","journal-title":"Cell Mol Life Sci"},{"issue":"1-2","key":"3813_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2003.08.007","volume":"209","author":"N Chegini","year":"2003","unstructured":"Chegini N, Luo X, Ding L, Ripley D. The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol. 2003;209(1-2):9\u201316.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"3813_CR26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2012.04.002","volume":"98","author":"SA Salama","year":"2012","unstructured":"Salama SA, Diaz-Arrastia CR, Kilic GS, Kamel MW. 2-Methoxyestradiol causes functional repression of transforming growth factor \u03b23 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells. Fertil Steril. 2012;98(1):178\u201384.","journal-title":"Fertil Steril"},{"issue":"3","key":"3813_CR27","first-page":"921","volume":"15","author":"E Tulchinsky","year":"2000","unstructured":"Tulchinsky E. Fos family members: regulation, structure and role in oncogenic transformation. Histol Histopathol. 2000;15(3):921\u20138.","journal-title":"Histol Histopathol"},{"issue":"2","key":"3813_CR28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10911-011-9203-7","volume":"16","author":"AM Band","year":"2011","unstructured":"Band AM, Laiho M. Crosstalk of TGF-\u03b2 and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia. 2011;16(2):109\u201315.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"8","key":"3813_CR29","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1349-7006.2011.01977.x","volume":"102","author":"N Goto","year":"2011","unstructured":"Goto N, Hiyoshi H, Ito I, Tsuchiya M, Nakajima Y, Yanagisawa J. Estrogen and antiestrogens alter breast cancer invasiveness by modulating the transforming growth factor-\u03b2 signaling pathway. Cancer Sci. 2011;102(8):1501\u20138.","journal-title":"Cancer Sci"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3813-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3813-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3813-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3813-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:29:28Z","timestamp":1559489368000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3813-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3813"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3813-4","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}